Browse > Article

Caregiver or Family Doses due to Discharged $^{131}I$ Administrated Patient from the Hospital  

Jeong, Gyu-Hwan (Korea Institute of Nuclear Safety)
Lee, Hyun-Kook (Department of Nuclear Medicine of Eulji Medical Center)
Cho, Woon-Kap (Korea Institute of Nuclear Safety)
Lee, Jai-Ki (Department of Nuclear Engineering in Hanyang University)
Publication Information
Journal of radiological science and technology / v.33, no.2, 2010 , pp. 149-154 More about this Journal
Abstract
Exposed doses to the patient's caregiver and their house due to the 131I from patients discharged from the hospital were measured using OSL dosimeters. Usually, 3.37-5.55 GBq (100-150 mCi) of $^{131}I$ administrated patients are discharged from the hospital after 3 or 4 days of hospitalization in Korea. In addition, after 5 to 8 days, the accumulated doses of the patient's caregiver and house after hospitalization of the patient were measured using OSL dosimeters. The results of the measured average accumulated doses were 0.1 mSv, which is 10% of 1 mSv, the public dose limit in the Korean Atomic Energy Law. And it's standard deviation was 0.087 mSv. Based on the results of this study, we anticipate that we could assure the compliance of the regulation requirement 5 mSv of MEST (Ministry of Education, Science and Technology) Notice No. 2008-45 for the patient's caregiver or family, even if we reduce the 3-4 days of hospitalization to 1-2 days or less.
Keywords
radioiodine $^{131}I$; external dose; nuclear medicine; OSL dosimeter; caregiver;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 박석건, I-131 치료를 받은 분화갑상선암 환자에서 I-131의 유효반감기, NuclMedMolImaging Vol. 42, No. 6. 464-468, 2008   과학기술학회마을
2 Park H, Jang J, Yang H, Kim Y. Outpatient Radioablation Therapy for Thyroid Cancer Patients with Minimal Radiation Exposure to the Family Members. NuclMedMolImaging, 41: 218-25, 2007   과학기술학회마을
3 Pant GS, Sharma SK, Bal CS, Kumar R, Rath GK. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I. RadiatProtDosimetry, 118:22-7, 2006   DOI
4 de Carvalho J, Sapienza M, Ono C, Watanabe T, Guimaraes M, Gutterres R, et al. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe? NuclMedCommun 30:533-41, 2009   DOI   ScienceOn
5 교육과학기술부고시 제2008-45호 "의료분야의 방사선 안전관리에 관한 기술기준 고시" 2008
6 U.S. Nuclear Regulatory Commission, NUREG- 1566, Vol. 9, Rev. 2, Consolidated Guidance About Materials Licenses - Program-Specific Guidance About Medical Use Licenses Final Report appendix U. January 2008